SUBSCRIBERS
Cordlife to buy cord blood bank HealthBaby
Published Wed, Jan 3, 2018 · 09:50 PM
Singapore
IN a bid to expand its presence in Hong Kong and Macau, Singapore-listed consumer healthcare company Cordlife Group has signed an agreement to buy out private cord blood bank HealthBaby Biotech (Hong Kong) Co from Stemgen Biotech Holding.
As part of the transaction, Cordlife will assume the debt of HK$138.2 million (S$23.8 million) which Stemgen Biotech Holding owed to HealthBaby Hong Kong.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
China’s top airlines improve balance sheet in Q1; outlook positive for May Day
Stablecoin issuer Tether invests US$200 million in brain-computer interface company
Yahoo to lay off staff in Singapore as it shifts to content curation
US: Wall St opens higher on megacap strength, Fed verdict awaited
IReit Global occupancy rate grows to 91.5% in Q1
Yen surges against US dollar on suspected intervention